Оценка эффективности применения рекомбинантного интерлейкина-2 (ронколейкина) в комплексном лечении пациентов со стероидозависимой бронхиальной астмой

The patients with steroid-dependent bronchial asthma were revealed to have T-cell immunity and depression of phagocyte and compensatory activation of humoral immunity. The complex treatment with the usage of roncoleukin led to the normalization of the basic quantitative and functional parameters of T-cell immunity, stabilized the humoral and neutrophilic phagocytosis. The removal of immunological disorders was accompanied by the expressed clinical effect.